Sodium Acetate Injection
Hospira, Inc., a Pfizer Company · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/03/2016
- Package NDC
- 0409-7299-25
- Generic name
- Sodium Acetate Injection
- Contact info
- 844-646-4398
- Availability
- Available
- Update date
- 10/21/2026
- Dosage form
- Injection
- Presentation
- Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)
- Company name
- Hospira, Inc., a Pfizer Company
- Status
- Current
- Therapeutic category
- Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition
- Harmonized identifiers (openFDA)
- Application number
- NDA018893
- Brand name
- SODIUM ACETATE
- Generic name
- SODIUM ACETATE
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-7299
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- SODIUM ACETATE ANHYDROUS
- RxCUI
- 1859490
- SPL ID
- 013001c4-5584-4d8c-8bf6-917d2a919aa4, 10c75a24-9542-431a-84f8-44611bc916df
- SPL set ID
- ce9a7469-c4ba-4f60-8f7a-47ef0974316e, c91ede49-c7cc-47b7-0f93-e6841dd5916a
- Package NDC
- 0409-7299-45, 0409-7299-25, 0409-7299-83, 0409-7299-73
- UNII
- NVG71ZZ7P0